List of Tables
Table 1. Novel Drug Delivery Systems for Cancer Therapy Market Trends
Table 2. Novel Drug Delivery Systems for Cancer Therapy Market Drivers & Opportunity
Table 3. Novel Drug Delivery Systems for Cancer Therapy Market Challenges
Table 4. Novel Drug Delivery Systems for Cancer Therapy Market Restraints
Table 5. Global Novel Drug Delivery Systems for Cancer Therapy Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Novel Drug Delivery Systems for Cancer Therapy Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Novel Drug Delivery Systems for Cancer Therapy Product Type
Table 9. Key Companies Time to Begin Mass Production of Novel Drug Delivery Systems for Cancer Therapy
Table 10. Global Novel Drug Delivery Systems for Cancer Therapy Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Drug Delivery Systems for Cancer Therapy as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Novel Drug Delivery Systems for Cancer Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Novel Drug Delivery Systems for Cancer Therapy Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Novel Drug Delivery Systems for Cancer Therapy Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Novel Drug Delivery Systems for Cancer Therapy Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Novel Drug Delivery Systems for Cancer Therapy Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Novel Drug Delivery Systems for Cancer Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Novel Drug Delivery Systems for Cancer Therapy Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Novel Drug Delivery Systems for Cancer Therapy Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Novel Drug Delivery Systems for Cancer Therapy Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Novel Drug Delivery Systems for Cancer Therapy Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Novel Drug Delivery Systems for Cancer Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Novel Drug Delivery Systems for Cancer Therapy Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Novel Drug Delivery Systems for Cancer Therapy Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Novel Drug Delivery Systems for Cancer Therapy Sales Value by Region (2019-2024) & (%)
Table 27. Global Novel Drug Delivery Systems for Cancer Therapy Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Novel Drug Delivery Systems for Cancer Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Novel Drug Delivery Systems for Cancer Therapy Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Novel Drug Delivery Systems for Cancer Therapy Sales Value, (2025-2030) & (US$ Million)
Table 31. Advanced Medical Isotope Corporation Basic Information List
Table 32. Advanced Medical Isotope Corporation Description and Business Overview
Table 33. Advanced Medical Isotope Corporation Novel Drug Delivery Systems for Cancer Therapy Products, Services and Solutions
Table 34. Revenue (US$ Million) in Novel Drug Delivery Systems for Cancer Therapy Business of Advanced Medical Isotope Corporation (2019-2024)
Table 35. Advanced Medical Isotope Corporation Recent Developments
Table 36. Bind Therapeutics Basic Information List
Table 37. Bind Therapeutics Description and Business Overview
Table 38. Bind Therapeutics Novel Drug Delivery Systems for Cancer Therapy Products, Services and Solutions
Table 39. Revenue (US$ Million) in Novel Drug Delivery Systems for Cancer Therapy Business of Bind Therapeutics (2019-2024)
Table 40. Bind Therapeutics Recent Developments
Table 41. Boston Scientific Corporation Basic Information List
Table 42. Boston Scientific Corporation Description and Business Overview
Table 43. Boston Scientific Corporation Novel Drug Delivery Systems for Cancer Therapy Products, Services and Solutions
Table 44. Revenue (US$ Million) in Novel Drug Delivery Systems for Cancer Therapy Business of Boston Scientific Corporation (2019-2024)
Table 45. Boston Scientific Corporation Recent Developments
Table 46. BTG plc Basic Information List
Table 47. BTG plc Description and Business Overview
Table 48. BTG plc Novel Drug Delivery Systems for Cancer Therapy Products, Services and Solutions
Table 49. Revenue (US$ Million) in Novel Drug Delivery Systems for Cancer Therapy Business of BTG plc (2019-2024)
Table 50. BTG plc Recent Developments
Table 51. CeloNova BioSciences, Inc. Basic Information List
Table 52. CeloNova BioSciences, Inc. Description and Business Overview
Table 53. CeloNova BioSciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Products, Services and Solutions
Table 54. Revenue (US$ Million) in Novel Drug Delivery Systems for Cancer Therapy Business of CeloNova BioSciences, Inc. (2019-2024)
Table 55. CeloNova BioSciences, Inc. Recent Developments
Table 56. Cook Medical, Inc. Basic Information List
Table 57. Cook Medical, Inc. Description and Business Overview
Table 58. Cook Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Products, Services and Solutions
Table 59. Revenue (US$ Million) in Novel Drug Delivery Systems for Cancer Therapy Business of Cook Medical, Inc. (2019-2024)
Table 60. Cook Medical, Inc. Recent Developments
Table 61. Cospheric LLC Basic Information List
Table 62. Cospheric LLC Description and Business Overview
Table 63. Cospheric LLC Novel Drug Delivery Systems for Cancer Therapy Products, Services and Solutions
Table 64. Revenue (US$ Million) in Novel Drug Delivery Systems for Cancer Therapy Business of Cospheric LLC (2019-2024)
Table 65. Cospheric LLC Recent Developments
Table 66. Covidien, plc Basic Information List
Table 67. Covidien, plc Description and Business Overview
Table 68. Covidien, plc Novel Drug Delivery Systems for Cancer Therapy Products, Services and Solutions
Table 69. Revenue (US$ Million) in Novel Drug Delivery Systems for Cancer Therapy Business of Covidien, plc (2019-2024)
Table 70. Covidien, plc Recent Developments
Table 71. Eckert & Ziegler BEBIG Basic Information List
Table 72. Eckert & Ziegler BEBIG Description and Business Overview
Table 73. Eckert & Ziegler BEBIG Novel Drug Delivery Systems for Cancer Therapy Products, Services and Solutions
Table 74. Revenue (US$ Million) in Novel Drug Delivery Systems for Cancer Therapy Business of Eckert & Ziegler BEBIG (2019-2024)
Table 75. Eckert & Ziegler BEBIG Recent Developments
Table 76. EmboMedics, Inc. Basic Information List
Table 77. EmboMedics, Inc. Description and Business Overview
Table 78. EmboMedics, Inc. Novel Drug Delivery Systems for Cancer Therapy Products, Services and Solutions
Table 79. Revenue (US$ Million) in Novel Drug Delivery Systems for Cancer Therapy Business of EmboMedics, Inc. (2019-2024)
Table 80. EmboMedics, Inc. Recent Developments
Table 81. Kobo Products, Inc. Basic Information List
Table 82. Kobo Products, Inc. Description and Business Overview
Table 83. Kobo Products, Inc. Novel Drug Delivery Systems for Cancer Therapy Products, Services and Solutions
Table 84. Revenue (US$ Million) in Novel Drug Delivery Systems for Cancer Therapy Business of Kobo Products, Inc. (2019-2024)
Table 85. Kobo Products, Inc. Recent Developments
Table 86. Merit Medical Systems, Inc. Basic Information List
Table 87. Merit Medical Systems, Inc. Description and Business Overview
Table 88. Merit Medical Systems, Inc. Novel Drug Delivery Systems for Cancer Therapy Products, Services and Solutions
Table 89. Revenue (US$ Million) in Novel Drug Delivery Systems for Cancer Therapy Business of Merit Medical Systems, Inc. (2019-2024)
Table 90. Merit Medical Systems, Inc. Recent Developments
Table 91. Mo-Sci Corporation Basic Information List
Table 92. Mo-Sci Corporation Description and Business Overview
Table 93. Mo-Sci Corporation Novel Drug Delivery Systems for Cancer Therapy Products, Services and Solutions
Table 94. Revenue (US$ Million) in Novel Drug Delivery Systems for Cancer Therapy Business of Mo-Sci Corporation (2019-2024)
Table 95. Mo-Sci Corporation Recent Developments
Table 96. Nanobiotix Basic Information List
Table 97. Nanobiotix Description and Business Overview
Table 98. Nanobiotix Novel Drug Delivery Systems for Cancer Therapy Products, Services and Solutions
Table 99. Revenue (US$ Million) in Novel Drug Delivery Systems for Cancer Therapy Business of Nanobiotix (2019-2024)
Table 100. Nanobiotix Recent Developments
Table 101. Polysciences, Inc. Basic Information List
Table 102. Polysciences, Inc. Description and Business Overview
Table 103. Polysciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Products, Services and Solutions
Table 104. Revenue (US$ Million) in Novel Drug Delivery Systems for Cancer Therapy Business of Polysciences, Inc. (2019-2024)
Table 105. Polysciences, Inc. Recent Developments
Table 106. Sirtex Medical, Inc. Basic Information List
Table 107. Sirtex Medical, Inc. Description and Business Overview
Table 108. Sirtex Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Products, Services and Solutions
Table 109. Revenue (US$ Million) in Novel Drug Delivery Systems for Cancer Therapy Business of Sirtex Medical, Inc. (2019-2024)
Table 110. Sirtex Medical, Inc. Recent Developments
Table 111. Terumo Corporation Basic Information List
Table 112. Terumo Corporation Description and Business Overview
Table 113. Terumo Corporation Novel Drug Delivery Systems for Cancer Therapy Products, Services and Solutions
Table 114. Revenue (US$ Million) in Novel Drug Delivery Systems for Cancer Therapy Business of Terumo Corporation (2019-2024)
Table 115. Terumo Corporation Recent Developments
Table 116. Key Raw Materials Lists
Table 117. Raw Materials Key Suppliers Lists
Table 118. Novel Drug Delivery Systems for Cancer Therapy Downstream Customers
Table 119. Novel Drug Delivery Systems for Cancer Therapy Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 123. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Novel Drug Delivery Systems for Cancer Therapy Product Picture
Figure 2. Global Novel Drug Delivery Systems for Cancer Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Novel Drug Delivery Systems for Cancer Therapy Sales Value (2019-2030) & (US$ Million)
Figure 4. Novel Drug Delivery Systems for Cancer Therapy Report Years Considered
Figure 5. Global Novel Drug Delivery Systems for Cancer Therapy Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Novel Drug Delivery Systems for Cancer Therapy Revenue in 2023
Figure 7. Novel Drug Delivery Systems for Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Embolization Particles – Drug Eluting Beads Picture
Figure 9. Polyvinyl Alcohol Particles Picture
Figure 10. Microspheres Picture
Figure 11. Gelatin-Based Embolization Devices Picture
Figure 12. Selective Internal Radiation Therapy Picture
Figure 13. Holmium-Based Microspheres Picture
Figure 14. Liquid Embolics – Onyx Picture
Figure 15. Other Picture
Figure 16. Global Novel Drug Delivery Systems for Cancer Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Novel Drug Delivery Systems for Cancer Therapy Sales Value Market Share by Type, 2023 & 2030
Figure 18. Product Picture of Hospitals
Figure 19. Product Picture of Clinics
Figure 20. Product Picture of Others
Figure 21. Global Novel Drug Delivery Systems for Cancer Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Novel Drug Delivery Systems for Cancer Therapy Sales Value Market Share by Application, 2023 & 2030
Figure 23. North America Novel Drug Delivery Systems for Cancer Therapy Sales Value (2019-2030) & (US$ Million)
Figure 24. North America Novel Drug Delivery Systems for Cancer Therapy Sales Value by Country (%), 2023 VS 2030
Figure 25. Europe Novel Drug Delivery Systems for Cancer Therapy Sales Value (2019-2030) & (US$ Million)
Figure 26. Europe Novel Drug Delivery Systems for Cancer Therapy Sales Value by Country (%), 2023 VS 2030
Figure 27. Asia Pacific Novel Drug Delivery Systems for Cancer Therapy Sales Value (2019-2030) & (US$ Million)
Figure 28. Asia Pacific Novel Drug Delivery Systems for Cancer Therapy Sales Value by Country (%), 2023 VS 2030
Figure 29. South America Novel Drug Delivery Systems for Cancer Therapy Sales Value (2019-2030) & (US$ Million)
Figure 30. South America Novel Drug Delivery Systems for Cancer Therapy Sales Value by Country (%), 2023 VS 2030
Figure 31. Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Sales Value (2019-2030) & (US$ Million)
Figure 32. Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Sales Value by Country (%), 2023 VS 2030
Figure 33. Key Countries/Regions Novel Drug Delivery Systems for Cancer Therapy Sales Value (%), (2019-2030)
Figure 34. United States Novel Drug Delivery Systems for Cancer Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 35. United States Novel Drug Delivery Systems for Cancer Therapy Sales Value by Type (%), 2023 VS 2030
Figure 36. United States Novel Drug Delivery Systems for Cancer Therapy Sales Value by Application (%), 2023 VS 2030
Figure 37. Europe Novel Drug Delivery Systems for Cancer Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 38. Europe Novel Drug Delivery Systems for Cancer Therapy Sales Value by Type (%), 2023 VS 2030
Figure 39. Europe Novel Drug Delivery Systems for Cancer Therapy Sales Value by Application (%), 2023 VS 2030
Figure 40. China Novel Drug Delivery Systems for Cancer Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 41. China Novel Drug Delivery Systems for Cancer Therapy Sales Value by Type (%), 2023 VS 2030
Figure 42. China Novel Drug Delivery Systems for Cancer Therapy Sales Value by Application (%), 2023 VS 2030
Figure 43. Japan Novel Drug Delivery Systems for Cancer Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 44. Japan Novel Drug Delivery Systems for Cancer Therapy Sales Value by Type (%), 2023 VS 2030
Figure 45. Japan Novel Drug Delivery Systems for Cancer Therapy Sales Value by Application (%), 2023 VS 2030
Figure 46. South Korea Novel Drug Delivery Systems for Cancer Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 47. South Korea Novel Drug Delivery Systems for Cancer Therapy Sales Value by Type (%), 2023 VS 2030
Figure 48. South Korea Novel Drug Delivery Systems for Cancer Therapy Sales Value by Application (%), 2023 VS 2030
Figure 49. Southeast Asia Novel Drug Delivery Systems for Cancer Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 50. Southeast Asia Novel Drug Delivery Systems for Cancer Therapy Sales Value by Type (%), 2023 VS 2030
Figure 51. Southeast Asia Novel Drug Delivery Systems for Cancer Therapy Sales Value by Application (%), 2023 VS 2030
Figure 52. India Novel Drug Delivery Systems for Cancer Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 53. India Novel Drug Delivery Systems for Cancer Therapy Sales Value by Type (%), 2023 VS 2030
Figure 54. India Novel Drug Delivery Systems for Cancer Therapy Sales Value by Application (%), 2023 VS 2030
Figure 55. Novel Drug Delivery Systems for Cancer Therapy Industrial Chain
Figure 56. Novel Drug Delivery Systems for Cancer Therapy Manufacturing Cost Structure
Figure 57. Channels of Distribution (Direct Sales, and Distribution)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
